Skip to content

IMA - ImageneBio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

ImageneBio, Inc.

IMA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IMAImageneBio, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $14.34
52-wk low: $3.94
Prev close: $9.06
Mkt cap: $64.6M
P/S: 83.3x
P/B: 0.5x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$2.2M

JS
Jim Simons
Q2 2026 13F
$513K
position
SQ
Squarepoint
Q4 2025 13F

Earnings

Reported Jul 23, 2026

Earnings came in 30.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $65M

Valuation

P/S83.32
P/B0.46

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IMA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $64.61M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-82.7%

$333K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$328K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IMA

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.63+30.0%

-$0.90 expected

Next report

What the street expects next

EPS expected

-$1.10

-$1.53 to -$0.84

Revenue expected

$0.00

3 analysts

Last 30 days

1up1down

Split both ways

Estimate drift

0.02

Change in 30 days

-82.7%

ROA-43.1%

Growth